Nottingham, United Kingdom

Tim Luker

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tim Luker: Innovator in Central Nervous System Treatments

Introduction

Tim Luker is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for diseases related to the central nervous system. With a total of 2 patents, his work is recognized for its potential impact on therapeutic practices.

Latest Patents

Tim Luker's latest patents include innovative compounds designed for therapeutic use. One of his patents focuses on N-(hetero)aryl-substituted heterocyclic derivatives, which are useful for treating conditions related to the central nervous system. This invention provides compounds of formula (I), compositions comprising such compounds, and methods for treating patients by inhibiting dopamine transporters. Another patent involves spirocyclic derivatives, which also target similar therapeutic applications. These compounds are defined by specific structural components, including R, Q, X, Y, Z, A, L, B, m, n, and p.

Career Highlights

Tim Luker is currently associated with Chronos Therapeutics Limited, where he continues to advance his research and development efforts. His work is pivotal in exploring new avenues for treating neurological disorders, showcasing his commitment to innovation in the pharmaceutical industry.

Collaborations

Tim collaborates with talented professionals in his field, including Susanna Cremonesi and Fabrizio Micheli. Their combined expertise enhances the research and development processes at Chronos Therapeutics Limited.

Conclusion

Tim Luker stands out as an influential inventor in the realm of central nervous system treatments. His patents reflect a dedication to improving therapeutic options for patients, and his ongoing work promises to contribute significantly to medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…